Loading term…
Periodic report (e.g., annually) summarizing benefit-risk of a medicine; replaces PADER in EU. Includes safety analyses and signal evaluation.
Annual PBRER submitted to EMA and FDA with cumulative safety data.
ICH E2C(R2), GVP Module VII
Cut-paste from previous PBRER without re-evaluation.
How do you ensure each PBRER reflects current benefit-risk?